Dietary therapy ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病3

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03266484
(ClinicalTrials.gov)
November 13, 201725/8/2017Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel DiseaseEffect of Dietary Therapy With a Probiotic Mixture on the Gut Microbiome and Fatigue Symptoms in Patients With Quiescent Inflammatory Bowel Disease - A Clinical TrialInflammatory Bowel Diseases;Crohn Disease;Ulcerative ColitisDietary Supplement: Probiotic Mixture;Dietary Supplement: PlaceboMassachusetts General HospitalWinclove Bio Industries BVActive, not recruiting18 Years75 YearsAll100N/AUnited States
2NCT02231814
(ClinicalTrials.gov)
December 201627/8/2014The Crohn's Disease Exclusion Diet With Partial Enteral Nutrition or Alone in Adult Patients With Crohn's DiseaseDietary Therapy Using the Crohn's Disease Exclusion Diet (CDED) With Partial Enteral Nutrition or Alone for Induction and Maintenance of Remission in in Adults With Mild to Moderate Crohn's Disease- A Pilot StudyCrohn's DiseaseDietary Supplement: Crohns Disease Exclusion Diet + PEN;Other: Crohns Disease Exclusion DietProf. Arie LevineNULLCompleted18 Years55 YearsAll40N/AIsrael
3NCT00343642
(ClinicalTrials.gov)
September 200621/6/2006Dietary Treatment of Crohn's DiseaseDietary Treatment of Crohn's DiseaseCrohn's Disease;Inflammatory Bowel DiseaseDietary Supplement: Time and attention + fructo-oligosaccharide placebo;Dietary Supplement: dietary therapy + fructo-oligosaccharide placebo;Drug: Time and attention + active fructooligosaccharide supplementationRush University Medical CenterNational Center for Complementary and Integrative Health (NCCIH)Completed18 Years80 YearsBoth73Phase 1/Phase 2United States